S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
National Heart, Lung, and Blood Institute and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary
Kathryn A. Taubert,M. Krumholz,Lori Mosca,Richard C. Pasternak,Thomas A. Pearson,Marc A. Pfeffer,Gregg C. Fonarow,Scott M. Grundy,Loren F. Hiratzka,Daniel Jones,J. T. Allen,Steven N. Blair,Robert O. Bonow +12 more
The Effect of Chenodeoxycholic Acid on Lipoproteins and Apolipoproteins
TL;DR: In this paper, the authors presented the results of a study at the Northwest Lipid Research Clinic, Harborview Medical Center and Department of Medicine, University of Washington School of Medicine.
Journal ArticleDOI
Association of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men.
Gloria Lena Vega,Gloria Lena Vega,Scott M. Grundy,Scott M. Grundy,Carolyn E. Barlow,David Leonard,Benjamin L. Willis,Laura F. DeFina,Stephen W. Farrell +8 more
TL;DR: A high TG/HDL-C ratio is common in men with low CRF and metabolic syndrome also is common among those with a high ratio.
Journal Article
Erratum: Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM (Diabetes (1989) 38 (364-72))
Abhimanyu Garg,Scott M. Grundy +1 more
Journal ArticleDOI
Statins: definitive translational research.
Scott M. Grundy,Scott M. Grundy +1 more
TL;DR: The discovery of the LDL receptor uncovered a potential pathway for markedly lowering levels of serum LDL and preventing atherosclerosis, the outgrowth of extensive research into cholesterol and lipoprotein metabolism, drug discovery and randomized clinical trials (RCTs).